When free is not fair: the case of vaccine donations

The Lancet Infectious Diseases

Volumn 17, Issue 2, 2017, Pages 128-130

  Smith, James ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; FLUCONAZOLE; GENERIC DRUG; IVERMECTIN; NEVIRAPINE; PNEUMOCOCCUS VACCINE;

CRYPTOCOCCAL MENINGITIS; DRUG COST; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG MARKETING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; NOTE; ONCHOCERCIASIS; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; PROGRAM SUSTAINABILITY; PUBLIC HEALTH CAMPAIGN; SOUTH AFRICA; TRACHOMA; VERTICAL TRANSMISSION; COMMUNITY CARE; ECONOMICS; GIFT GIVING; HEALTH CARE DELIVERY;

GIFT GIVING; HEALTH SERVICES ACCESSIBILITY; HUMANS; PNEUMOCOCCAL VACCINES; UNCOMPENSATED CARE;

EID: 85010912640     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30008-7     Document Type: Note

References (10)

1. 1 Cone, J, There is no such thing as “free” vaccines: why we rejected Pfizer's donation offer of pneumonia vaccines. http://www.doctorswithoutborders.org/article/there-no-such-thing-“free”-vaccines-why-we-rejected-pfizer's-donation-offer-pneumonia, 2016 (accessed Oct 17, 2016).
2. 2 Pérez-Casas, C, Chirac, P, Berman, D, Ford, N, Access to fluconazole in less-developed countries. Lancet, 356, 2000, 2102.
3. 3 Mbali, M, South African AIDS activism and global health politics, 2013, Palgrave Macmillan, London, 153–154.
4. 4 Mowjee, T, Campaign to increase access to HIV/AIDS drugs. Clark, J, (eds.) Globalising civic engagement: civil society and transnational action, 2003, Earthscan Publications, London, 72–74.
5. 5 Brown, SA, Partnership prescriptions. Maclean, SJ, Brown, SA, Fourie, P, (eds.) Health for some: the political economy of global health governance, 2009, Palgrave Macmillan, New York, NY, 219.
6. 6 Bakan, J, The corporation: the pathological pursuit of profit and power, 2005, Free Press, New York, NY, 47.
7. 7 Baker, BK, Ombaka, E, The danger of in-kind drug donations to the Global Fund. Lancet 373 (2009), 1218–1221.
8. 8 MSF Access Campaign. The right shot: bringing down barriers to affordable and adapted vaccines, 2nd edn., 2015, Médecins Sans Frontières Access Campaign, Geneva, 76.
9. 9 Guilloux, A, Moon, S, Hidden price tags: disease-specific drug donations: costs and alternatives, 2001, Médecins Sans Frontières, Geneva.
10. 10 Pérez-Casas, C, Herranz, E, Ford, N, Pricing of drugs and donations: options for sustainable equity pricing. Trop Med Int Health 6 (2001), 960–964.